Protagenic Therapeutics, Inc.\new Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 0.00 shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 0.00 shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 360.00K shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 10.00K shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 370.00K shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | 370.00K shares 10-K · filed 2022-04-07 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | |
| 2021-06-30 | 360.00K shares 10-Q · filed 2021-11-15 | |
| 2021-03-31 | 10.00K shares 10-Q · filed 2021-05-17 | |
| 2016-12-31 | 25.00K shares 10-K/A · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |